Ultra-processed foods, risk for Crohn’s disease
Rising rates of ultra-processed food consumption correlated with an increased risk for Crohn’s disease, according to a presentation at Digestive...
Apixaban lowers valve thrombosis risk, does not affect ischemic events post-TAVR
Apixaban reduced valve thrombosis at 90 days after transcatheter aortic valve replacement, but there was no difference in ischemic outcomes at 1...
FDA approves Opdivo for esophageal, gastroesophageal junction cancers
The FDA approved nivolumab as adjuvant treatment for certain patients with completely resected esophageal or gastroesophageal junction cancers,...
Increased systemic inflammation linked to symptomatic COVID-19
Although the seroprevalence of SARS-CoV-2 in patients with immune-mediated inflammatory diseases is comparable to the general population,...
Treatment with gene-edited cell therapies not associated with subsequent cancer risk
Patients with cancer who received genetically modified immune effector cells did not demonstrate increased risk for developing subsequent...
Multiple disease progression events less likely with continued inhaled treprostinil
In a post hoc analysis of the INCREASE study, patients with interstitial lung disease-associated pulmonary hypertension who continued inhaled...
Mulberry twig alkaloids lower HbA1c with fewer gastrointestinal effects vs. acarbose
Chinese adults with type 2 diabetes achieved a 0.93% HbA1c reduction with 24 weeks of mulberry twig alkaloid therapy, an outcome comparable with...
Intraoperative transesophageal echocardiography may lower mortality risk after CABG
Intraoperative transesophageal echocardiography during CABG was associated with lower odds of 30-day mortality, particularly among higher-risk...



